Secondary Loss of Response to Infliximab in Pediatric Crohn Disease: Does It Matter How and When We Start?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Secondary Loss of Response to Infliximab in Pediatric Crohn Disease: Does It Matter How and When We Start?

Published:2018-04 Issue:4 Volume:66 Page:637-640
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology & Nutrition
language:en
Short-container-title:

Author:

Bolia Rishi,Rosenbaum Jeremy,Schildkraut Vered,Hardikar Winita,Oliver Mark,Cameron Donald,Alex George

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology and Child Health

Reference25 articles.

1. Natural history of Crohn's disease: comparison between childhood- and adult-onset disease;Pigneur;Inflamm Bowel Dis,2010

2. Effectiveness of anti-TNFα for Crohn disease: research in a pediatric learning health system;Forrest;Pediatrics,2014

3. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children;Hyams;Gastroenterology,2007

4. Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy;Sokol;Gut,2010

5. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease;Ruemmele;J Crohns Colitis,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacologic Management of Monogenic and Very Early Onset Inflammatory Bowel Diseases;Pharmaceutics;2023-03-17

2. Quality Improvement Methodology Optimizes Infliximab Levels in Pediatric Patients with Inflammatory Bowel Disease;Pediatric Quality & Safety;2021-05

3. Early Infliximab in Crohn’s is associated with decreased intestinal surgery and similar health care costs;Scandinavian Journal of Gastroenterology;2021-02-17

4. Systematic review and meta-analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn’s disease;Alimentary Pharmacology & Therapeutics;2020-03-23

5. Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease;Journal of Pediatric Gastroenterology & Nutrition;2019-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3